Core needle biopsy proves safe for patients taking anticoagulants

October 27, 2008 Core needle biopsy proves safe for patients taking anticoagulants Radiologists can breathe easier about the risk of patient bleeding and bruising when performing core needle breast biopsies on women who take daily anticoagulant aspirin or therapeutically-in-range warfarin, according to a new study. In the past, patients were advised to cease anticoagulation therapy for one week before undergoing core needle breast biopsy. Radiologists found, however, that stopping anticoagulation therapy was not always possible because of underlying medical reasons or time constraints. Scheduling a follow-up appointment to perform the biopsy also proved problematic, as patients were more likely to miss their follow-up appointment.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC